Overcoming conventional technological limitations to realize high-speed optical coherence modulation at 350 kHz. Structured light fields possess a wide range of unique and powerful characteristics. By ...

Accommodations for progressive functional impairment due to Duchenne muscular dystrophy (DMD) incur substantial costs for households in the US, according to a survey of US-based family-member ...

Precision BioSciences stated it is advancing final IND-enabling toxicology studies and working with DMD clinicians to design initial human trials, with clinical data expected in 2026.

The human microbiome is an ecosystem of microorganisms composed primarily of bacteria that symbiotically interact with the body. 1 The gut microbiome's interplay with the immune system makes ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing ...

In other recent news, Precision BioSciences has made significant strides in its efforts to treat Duchenne muscular dystrophy (DMD). The company announced that its gene editing therapy, PBGENE-DMD, ...

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the deaths of two Duchenne muscular dystrophy (DMD) patients following ...

Santhera's Duchenne muscular dystrophy (DMD) therapy Agamree has been cleared for NHS use after a confidential pricing agreement.

People with a DMD diagnosis must believe this isn’t a sign to roll the end credits on their lives, says Luca Buccella.

Despite the risks of gene therapy, “we chose the risk of action over reticence,” write two Duchenne mothers.